Skip to main content
    E

    Erasca Inc (ERAS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $13.89
    -1.22 (-8.07%)

    Market Cap: $5.50B

    Last updated: Nov 17, 2026 at 4:41 PM ET

    Erasca Inc (ERAS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Erasca (ERAS) has a market cap of $5.50B and an enterprise value of $5.38B. Its share count is up 21.35% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 2.16% below the market cap, as cash exceeds debt.

    Market Cap$5.50B
    Enterprise Value$5.38B
    Latest price (Nov 17, 2026)$13.89

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 10.57% in the quarter ended Sep 30, 2026 and grew 10.41% a year over 2 years.

    Shares Outstanding344.24M
    Shares Change (YoY)+21.35%
    Shares Change (QoQ)+10.57%
    Share Count Growth (2Y CAGR)+10.41%

    Price Statistics

    The stock is up 438.37% over 52 weeks and trades 6.72% below its 50-day average.

    Beta (1Y)1.85
    52-Week Change+438.37%
    1-Month Change+1.98%
    3-Month Change-23.13%
    6-Month Change+34.59%
    5-Year Change-27.45%
    Total Return (1Y)+438.37%
    Total Return (3Y CAGR)+82.35%
    Total Return (5Y CAGR)-5.29%
    Return vs SPY (1Y)+374.11%
    Max Drawdown (1Y)-59.46%
    Max Drawdown (3Y)-67.68%
    Sharpe Ratio (1Y)1.46
    Correlation with SPY (1Y)0.24
    50-Day Average$14.89
    200-Day Average$15.30
    52-Week Range$2.75 to $24.28
    RSI (14 Days)43.6
    Average Volume (20 Days)5.31M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 14.89x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio14.89x
    Quick Ratio14.89x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -33.59% over the last 12 months, against a 5-year average of -40.36%.

    Return on Equity (ROE)-33.59%
    Return on Assets (ROA)-30.83%
    ROE (5Y Average)-40.36%
    ROA (5Y Average)-33.38%
    ROIC (5Y Average)-34.29%

    Scores

    ERAS has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$743.00K
    Operating Income-$327.65M
    Pretax Income-$307.94M
    Net Income-$307.94M
    Reported EPS (TTM)-$0.99

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 91.77% of the $998.94M in total assets.

    Cash and Equivalents$118.96M
    Total Debt$0
    Net Cash$118.96M
    Net Cash Per Share$0.35
    Working Capital$611.20M
    Shareholder Equity$916.74M
    Book Value Per Share$2.66
    Total Assets$998.94M
    Total Liabilities$82.20M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $132.00K of capital spending, operating cash flow left -$109.24M of free cash flow.

    Operating Cash Flow-$109.11M
    Capital Expenditures$132.00K
    Free Cash Flow-$109.24M
    FCF Per Share-$0.31
    Depreciation and Amortization$6.54M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    ERAS does not pay a dividend. Its free cash flow yield is -2.28%.

    FCF Yield-2.28%
    Buyback Yield-17.51%
    Shareholder Yield-17.51%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About ERAS

    What is ERAS's market cap?

    Erasca has a market cap of $5.50B. Its enterprise value, which adds debt and subtracts cash, is $5.38B.

    How many shares of ERAS are outstanding?

    Erasca has 344.24M shares outstanding. The count is up 21.35% from a year earlier.

    Does ERAS pay a dividend?

    No. Erasca does not pay a dividend.

    How much debt does ERAS have?

    Erasca has $0 of total debt and $118.96M of cash and equivalents, a net cash position of $118.96M.